Although artificial intelligence in health has shown great promise, pressure is mounting for regulators around the world to act, as AI tools demonstrate potentially harmful outcomes.
MIT Sloan Action Learning - In each project the ultimate goal is to improve the quality of healthcare and patient outcomes.
On March 4, 2025, HSI hosted the third seminar in its Scale Up Health series, which focused on the Healthcare Talent Imperative.
Keynote Speaker Jim Davis, CEO of Quest Diagnostics, Focuses on Diagnostics, AI in Pathology, and Health Span
Healthcare Lab, one of the required courses for the MIT Sloan healthcare certificate, is an opportunity for students to gain insight into real-world challenges in healthcare.
On February 23, 2024, The MIT Sloan Healthcare Club convened the 22nd annual MIT Sloan Healthcare and Bioinnovations Conference.
The MIT Sloan Health Systems Initiative discovers transformative and sustainable innovations that improve health by engaging world-class researchers with health systems leaders.
This session will explore how AI agents are impacting the pharmaceutical landscape from initial drug discovery to successful commercialization.
